🔴 SGL2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic Kidney Disease
✅SGLT2i use was associated with a lower risk for dialysis, cardiovascular events, DKA, and AKI than no SGLT2i use in patients with T2D and stage 5 CKD.
✅https://www.acpjournals.org/doi/10.7326/M23-1874?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
#MedX #MedTwitter #CardioTwitter
#medx #medEd #MedTwitter #MedEd #cardiotwitter #FOAMed #CardioEd #Cardiology #MedEd #ENARM #cardiotwiteros #meded #cardiology #CardioTwitter #CardioEd #medtwitterWhat
✅SGLT2i use was associated with a lower risk for dialysis, cardiovascular events, DKA, and AKI than no SGLT2i use in patients with T2D and stage 5 CKD.
✅https://www.acpjournals.org/doi/10.7326/M23-1874?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
#MedX #MedTwitter #CardioTwitter
#medx #medEd #MedTwitter #MedEd #cardiotwitter #FOAMed #CardioEd #Cardiology #MedEd #ENARM #cardiotwiteros #meded #cardiology #CardioTwitter #CardioEd #medtwitterWhat
Annals of Internal Medicine
Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Dialysis and Cardiovascular Disease in Patients With Stage 5 Chronic…
Background: No studies have reported the long-term outcomes of initiating sodium–glucose cotransporter-2 inhibitors (SGLT2is) in patients with estimated glomerular filtration rates less than 20 mL/min/1.73 m2 to predialysis. Objective: To compare the risk…
❤5
🔴Antihypertensive drugs recommended in pregnancy and Hypertension💊⤵️
#Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical #medEd #cardiotwitter #medicineball
#Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular #MedTwitter #medical #medEd #cardiotwitter #medicineball
❤2